"Global Inactivated Poliovirus Vaccine Market Overview:
Global Inactivated Poliovirus Vaccine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Inactivated Poliovirus Vaccine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Inactivated Poliovirus Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Inactivated Poliovirus Vaccine Market:
The Inactivated Poliovirus Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Inactivated Poliovirus Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Inactivated Poliovirus Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Inactivated Poliovirus Vaccine market has been segmented into:
Monovalent IPV (mIPV
By Application, Inactivated Poliovirus Vaccine market has been segmented into:
tIPV
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Inactivated Poliovirus Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Inactivated Poliovirus Vaccine market.
Top Key Players Covered in Inactivated Poliovirus Vaccine market are:
GlaxoSmithKline
Sanofi
Astellas Pharma
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Kedrion Biopharma
Panacea Biotec Ltd.
Bilthoven Biologicals.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Inactivated Poliovirus Vaccine Market by Type
4.1 Inactivated Poliovirus Vaccine Market Snapshot and Growth Engine
4.2 Inactivated Poliovirus Vaccine Market Overview
4.3 Monovalent IPV (mIPV
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Monovalent IPV (mIPV: Geographic Segmentation Analysis
Chapter 5: Inactivated Poliovirus Vaccine Market by Application
5.1 Inactivated Poliovirus Vaccine Market Snapshot and Growth Engine
5.2 Inactivated Poliovirus Vaccine Market Overview
5.3 tIPV
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 tIPV: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Inactivated Poliovirus Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GLAXOSMITHKLINE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 SANOFI
6.4 ASTELLAS PHARMA
6.5 SERUM INSTITUTE OF INDIA PVT. LTD.
6.6 BHARAT BIOTECH
6.7 KEDRION BIOPHARMA
6.8 PANACEA BIOTEC LTD.
6.9 AND BILTHOVEN BIOLOGICALS.
Chapter 7: Global Inactivated Poliovirus Vaccine Market By Region
7.1 Overview
7.2. North America Inactivated Poliovirus Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Monovalent IPV (mIPV
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 tIPV
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Inactivated Poliovirus Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Monovalent IPV (mIPV
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 tIPV
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Inactivated Poliovirus Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Monovalent IPV (mIPV
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 tIPV
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Inactivated Poliovirus Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Monovalent IPV (mIPV
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 tIPV
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Inactivated Poliovirus Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Monovalent IPV (mIPV
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 tIPV
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Inactivated Poliovirus Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Monovalent IPV (mIPV
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 tIPV
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Inactivated Poliovirus Vaccine Scope:
|
Report Data
|
Inactivated Poliovirus Vaccine Market
|
|
Inactivated Poliovirus Vaccine Market Size in 2025
|
USD XX million
|
|
Inactivated Poliovirus Vaccine CAGR 2025 - 2032
|
XX%
|
|
Inactivated Poliovirus Vaccine Base Year
|
2024
|
|
Inactivated Poliovirus Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GlaxoSmithKline, Sanofi, Astellas Pharma, Serum Institute of India Pvt. Ltd., Bharat Biotech, Kedrion Biopharma, Panacea Biotec Ltd., and Bilthoven Biologicals..
|
|
Key Segments
|
By Type
Monovalent IPV (mIPV
By Applications
tIPV
|
